JP2009507077A5 - - Google Patents

Download PDF

Info

Publication number
JP2009507077A5
JP2009507077A5 JP2008530143A JP2008530143A JP2009507077A5 JP 2009507077 A5 JP2009507077 A5 JP 2009507077A5 JP 2008530143 A JP2008530143 A JP 2008530143A JP 2008530143 A JP2008530143 A JP 2008530143A JP 2009507077 A5 JP2009507077 A5 JP 2009507077A5
Authority
JP
Japan
Prior art keywords
amino acid
polypeptide
xaa
acid sequence
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008530143A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009507077A (ja
JP5329961B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/034603 external-priority patent/WO2007030475A1/en
Publication of JP2009507077A publication Critical patent/JP2009507077A/ja
Publication of JP2009507077A5 publication Critical patent/JP2009507077A5/ja
Application granted granted Critical
Publication of JP5329961B2 publication Critical patent/JP5329961B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008530143A 2005-09-06 2006-09-06 免疫介在性神経疾患を治療するための方法 Expired - Fee Related JP5329961B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US71418005P 2005-09-06 2005-09-06
US60/714,180 2005-09-06
US77518406P 2006-02-22 2006-02-22
US60/775,184 2006-02-22
US77985306P 2006-03-08 2006-03-08
US60/779,853 2006-03-08
PCT/US2006/034603 WO2007030475A1 (en) 2005-09-06 2006-09-06 Methods for treating immune mediated neurological diseases

Publications (3)

Publication Number Publication Date
JP2009507077A JP2009507077A (ja) 2009-02-19
JP2009507077A5 true JP2009507077A5 (enExample) 2009-10-22
JP5329961B2 JP5329961B2 (ja) 2013-10-30

Family

ID=37836151

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008530143A Expired - Fee Related JP5329961B2 (ja) 2005-09-06 2006-09-06 免疫介在性神経疾患を治療するための方法

Country Status (6)

Country Link
US (6) US20080207498A1 (enExample)
EP (1) EP1940436B1 (enExample)
JP (1) JP5329961B2 (enExample)
CN (1) CN101277714B (enExample)
CA (1) CA2621539C (enExample)
WO (1) WO2007030475A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005086947A2 (en) * 2004-03-10 2005-09-22 Trinity Therapeutics, Inc. Method for inhibiting immune complex formation in a subjetc
US20120021988A1 (en) * 2007-08-14 2012-01-26 Bodie Neil M Methods for treating immune thrombocytopenia
AU2008335245A1 (en) * 2007-12-11 2009-06-18 Genentech, Inc. Modulators of neuronal regeneration
WO2010009380A2 (en) * 2008-07-18 2010-01-21 Trinity Therapeutics, Inc. Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
CN104324359B (zh) * 2014-09-25 2016-08-17 中山大学 Rry三肽在制备治疗阿尔茨海默症药物中的用途
CN110684122B (zh) * 2019-10-29 2021-03-02 中国人民解放军军事科学院军事医学研究院 重组Tau表位嵌合多聚体抗原、其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189014A (en) * 1979-12-03 1993-02-23 Cowan Jr Fred M Method of treating cellular Fc receptor mediated hypersensitivity immune disorders
US5693758A (en) * 1987-11-19 1997-12-02 501 Research Corporation Limited Immunoglobulin E competitor
US5932483A (en) * 1990-10-16 1999-08-03 Northwestern University Synthetic peptide and its uses
EP0590058B1 (en) * 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US6420127B1 (en) * 1994-11-18 2002-07-16 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
JP2000505068A (ja) * 1996-03-13 2000-04-25 トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 補体活性化を阻害する新規ペプチド類
WO2001045746A2 (en) * 1999-12-24 2001-06-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
JP2004505609A (ja) * 2000-04-03 2004-02-26 オックスフォード　グリコサイエンシズ（ユーケー）　リミテッド 核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用
WO2002038592A2 (de) * 2000-11-08 2002-05-16 Affina Immuntechnik Gmbh Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
US6916904B2 (en) * 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
WO2005086947A2 (en) * 2004-03-10 2005-09-22 Trinity Therapeutics, Inc. Method for inhibiting immune complex formation in a subjetc

Similar Documents

Publication Publication Date Title
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
IL199263A (en) Glucagon peptide with enhanced solubility, pharmaceutical composition containing it and its uses for drug preparation
JP2011511753A5 (enExample)
JP2010534684A5 (enExample)
JP2019533722A5 (enExample)
JP2013515057A5 (enExample)
NZ599161A (en) Method for activation of helper t cell and composition for use in the method
PE20121393A1 (es) Analogo peptidico de oxintomodulina
MX2011011960A (es) Peptidos penetradores de celulas.
WO2009032749A3 (en) Salicylanilide modified peptides for use as oral therapeutics
JP2012518035A5 (enExample)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
TWI455721B (zh) 癌疫苗組合物
JP2012176978A5 (enExample)
JP2012500001A5 (enExample)
JP2008514618A5 (enExample)
WO2009025196A1 (ja) Foxm1ペプチドおよびこれを含む薬剤
JP2012115277A5 (enExample)
JP2011518179A5 (enExample)
IL276170B1 (en) Modified lipidated relaxin b chain peptides and their therapeutic use
JP2015509950A5 (enExample)
JP2006514104A5 (enExample)
JP2010536714A5 (enExample)
JP2012529293A5 (enExample)
MX2008009493A (es) Peptido novedoso y uso del mismo.